Gingival enlargement in children treated with antiepileptics

Journal of Child Neurology

Volumn 19, Issue 12, 2004, Pages 958-963

  Tan, Hüseyin ^a   Gürbüz, Taşkin ^b   Daǧsuyu, Ilhan Metin ^b  

^a ATATURK UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; VALPROIC ACID;

ARTICLE; BENIGN CHILDHOOD EPILEPSY; CHI SQUARE TEST; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FISHER EXACT TEST; GINGIVA HYPERTROPHY; GINGIVITIS; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TOOTH BRUSHING; TOOTH PLAQUE;

EID: 13444259692     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738040190120901     Document Type: Article

References (37)

1. Majola MP, McFadyen ML, Connolly C, et al: Factors influencing phenytoin-induced gingival enlargement. J Clin Periodontol 2000;27:506-512.
2. Thomason JM, Seymour RA, Rawlins MD: Incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients in general medical practice. Community Dent Oral Epidemiol 1992;20:288-291.
3. Ogunbodede EO, Adamolekun B, Akintomide AO: Oral health and dental treatment needs in Nigerian patients with epilepsy. Epilepsia 1998;39:590-594.
4. Perlík F, Kolínová M, Zvárová J, et al: Phenytoin as a risk factor in gingival hyperplasia. Ther Drug Monit 1995;17:445-448.
5. Delasnerie-Lauprêtre N, Turpin JC: Evaluation of the prevalence of side effects of phenobarbital in the Champagne-Ardenne reion (France). Pathol Biol 1991;39:780-784.
6. Katz J, Givol N, Chaushu G, et al: Vigabatrin-induced gingival overgrowth. J Clin Periodontol 1997;24:180-182.
7. Wondimu B, Sandberg J, Modéer T: Gingival overgrowth in renal transplant patients administered cyclosporin A in mixture or in capsule form. A longitudinal study. Clin Transplant 1996;10:71-76.
8. Somacarrera ML, Hernández G, Acero J, et al: Factors related to the incidence and severity of cyclosporin-induced gingival overgrowth in transplant patients. A longitudinal study. J Periodontol 1994;65:671-675.
9. Steele RM, Schuna AA, Schreiber RT: Calcium antagonist-induced gingival hyperplasia. Ann Intern Med 1994;120:663-664.
10. Miller CS, Damm DD: Incidence of verapamil-induced gingival hyperplasia in a dental population. J Periodontol 1992;63:453-456.
11. Bowman J, Levy B, Grubb R: Gingival overgrowth induced by diltiazem. Oral Surg Oral Med Oral Pathol 1988:65:183-185.
12. Fattore L, Stablein M, Bredfeldt G, et al: Gingival hyperplasia. A side effect of nifedipine and diltiazem. Spec Care Dent 1991;11:107-109.
13. Seymour RA: Calcium channel blockers and gingival overgrowth. Br Dent J 1991;170:376-379.
14. Bullón P, Machuca G, Martinez-Sahuquillo A, et al: Clinical assessment of gingival hyperplasia in patients treated with nifedipine. J Clin Peridontol 1994;21:256-259.
15. Kimball OP: The treatment of epilepsy with sodium diphenylhydantoinate. JAMA 1939;112:1244-1245.
16. Lundström A, Eeg-Olofsson O, Hamp SE: Effects of antiepileptic drug treatment with carbamazepine or phenytoin on the oral state of children and adolescents. J Clin Periodontol 1982;9: 482-488.
17. Seymour RA, Smith DG, Turnbull DN: The effects of phenytoin and sodium valproate on the periodontal health of adult epileptic patients. J Clin Periodontol 1985;12:413-419.
18. Dahllöf G, Axio E, Modéer T: Regression of phenytoin-induced gingival overgrowth after withdrawal of medication. Swed Dent J 1991;15:139-143.
19. Syrjanen S, Syrjanen K: Hyperplastic gingivitis in a child receiving sodium valproate treatment. Proc Finn Dent Soc 1979;75:95-98.
20. Russo LS: Valproate-induced stomatitis. Neurology 1981;31: 329-331.
21. Eeg-Olofsson O, Lundstrom A, Hamp SE: Oral state of children with epilepsy on treatment with sodium valproate. Scand J Dent Res 1983;91:219-223.
22. Löe H, Silness J: Periodontal diseases in pregnancy. Acta Odontol Scand 1963;21:533-551.
23. Löe H: The gingival index, the plaque index and the retention index systems. J Periodontol 1967;38(Suppl):610.
24. Silness J, Löe H: Periodontal diseases in pregnancy. Acta Odontol Scand 1964;22:121-135.
25. Listgarten MA: Periodontal probing: What does it mean? J Clin Periodontol 1980;7:165-176.
26. Angelopoulos AP, Goaz PW: Incidence of diphenylhydantoin hyperplasia. Oral Surg Oral Med Oral Pathol 1972;34:898-906.
27. Miranda J, Brunet L, Roset P, et al: Prevalence and risk of gingival enlargement in patients treated with nifedipine. J Periodontol 2001;72:605-611.
28. Brodie MJ, Dichter MA: Antiepileptic drugs. N Engl J Med 1996;334:168-175.
29. Ohtsuka Y, Amano R, Mizukawa M, et al: Treatment of intractable childhood epilepsy with high-dose valproate. Epilepsia 1992;33:158-164.
30. Dreiffus FE, Langer DH: Side effects of valproate. Am J Med 1988;(Suppl A):34-41.
31. Kamali F, McLaughlin WS, Ball DE, et al: The effect of multiple anticonvulsant therapy on the expression of phenytoin-induced gingival overgrowth. J Clin Periodontol 1999;26:802-805.
32. Brunet L, Miranda J, Roset P, et al: Prevalence and risk of gingival enlargement in patients treated with anticonvulsant drugs. Eur J Clin Invest 2001;31:781-788.
33. Brown RS, Beaver WT, Bottomley WK: On the mechanisms of drug induced gingival hyperplasia. J Oral Pathol Med 1991;20:201-209.
34. Hassell TM, Gilbert GH: Phenytoin sensitivity of fibroblasts as the basis for susceptibility to gingival enlargement. Am J Pathol 1983;112:218-223.
35. Modeer T, Domeij H, Anduren I, et al: Effect of phenytoin on the production of interleukin-6 and interleukin-8 in human gingival fibroblasts. J Oral Pathol Med 2000;29:491-499.
36. Hong HH, Trackman PC: Cytokine regulation of gingival fibroblast lysyl oxidase, collagen, and elastin. J Periodontol 2002; 73:145-152.
37. Sasaki T, Maita E: Increased bFGF level in the serum of patients with phenytoin-induced gingival overgrowth. J Clin Periodontol 1998;25:42-47.